Patients with metastatic colorectal cancer could find hope in new FDA-approved treatmentThis month brought some hopeful news for people who are battling metastatic colorectal cancer. The U.S. Food and Drug Administration (FDA) on Nov. 8 approved a new oral medicine called Fruzaqla (fruquintinib) for the treatment of patients with previously treated metastatic colorectal cancer . "An oral, chemotherapy-free option that offers a survival benefit despite treatment with prior therapies is a critical need for treating metastatic colorectal cancer." The Food and Drug Administration (FDA) approved Fruzaqla on Nov. 8 for the treatment of patients with previously treated metastatic colorectal cancer. Original article source: Patients with metastatic colorectal cancer could find hope in new FDA-approved treatment

Source: Fox News November 20, 2023 12:16 UTC